title: Phosphate interacts with PTHrP to regulate endochondral bone formation.
abstract: Phosphate and parathyroid hormone related peptide (PTHrP) are required for normal growth plate maturation. Hypophosphatemia impairs hypertrophic chondrocyte apoptosis leading to rachitic expansion of the growth plate; however, the effect of phosphate restriction on chondrocyte differentiation during endochondral bone formation has not been examined. Investigations were, therefore, undertaken to address whether phosphate restriction alters the maturation of embryonic d15.5 murine metatarsal elements. Metatarsals cultured in low phosphate media exhibited impaired chondrocyte differentiation, analogous to that seen with PTHrP-treatment of metatarsals cultured in control media. Because phosphate restriction acutely increases PTHrP expression in cultured metatarsals, studies were undertaken to determine if this increase in PTHrP plays a pathogenic role in the impaired chondrocyte differentiation observed under low phosphate conditions. In contrast to what was observed with wild-type metatarsal elements, phosphate restriction did not impair the differentiation of metatarsals isolated from PTHrP heterozygous or PTHrP knockout mice. In vivo studies in postnatal mice demonstrated that PTHrP haploinsufficiency also prevents the impaired hypertrophic chondrocyte apoptosis observed with phosphate restriction. To determine how signaling through the PTH/PTHrP receptor antagonizes the pro-apoptotic effects of phosphate, investigations were performed in primary murine hypertrophic chondrocytes. Receptor activation impaired phosphate-induced Erk1/2 phosphorylation specifically in the mitochondrial fraction and decreased levels of mitochondrial Bad, while increasing cytosolic phospho-Bad. Thus, these data demonstrate that phosphate restriction attenuates chondrocyte differentiation as well as impairing hypertrophic chondrocyte apoptosis and implicate a functional role for the PTH/PTHrP signaling pathway in the abnormalities in chondrocyte differentiation and hypertrophic chondrocyte apoptosis observed under phosphate restricted conditions.
authors: Division of Endocrinology, Diabetes, and Hypertension (E.S.L.), Brigham and Women's Hospital, Boston, Massachusetts 02115; Endocrine Unit (E.S.L., A.Z., B.T.C., E.D.Z., F.G., M.B.D.), Massachusetts General Hospital, Boston, Massachusetts 02114; Harvard Medical School (E.S.L., A.Z., F.G., M.B.D.), Boston, Massachusetts 02115.
authors: Eva S
authors: ES
authors: Liu
authors: Alena
authors: A
authors: Zalutskaya
authors: Byongsoo Timothy
authors: BT
authors: Chae
authors: Eric D
authors: ED
authors: Zhu
authors: Francesca
authors: F
authors: Gori
authors: Marie B
authors: MB
authors: Demay
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D019902:Chondrocytes / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D020219:Chondrogenesis / Q000187:drug effects / Q000502:physiology*; D004622:Embryo, Mammalian; D005260:Female; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D010012:Osteogenesis / Q000187:drug effects / Q000502:physiology*; D044162:Parathyroid Hormone-Related Protein / Q000378:metabolism* / Q000494:pharmacology; D010710:Phosphates / Q000172:deficiency / Q000378:metabolism*
chemical_list: D044162:Parathyroid Hormone-Related Protein; D010710:Phosphates; C018279:sodium phosphate